Patents by Inventor Yolanda Colson

Yolanda Colson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030055223
    Abstract: The present invention relates to monoclonal antibodies (MAb) to hematopoietic facilitatory cells (FC). In particular, it relates to MAb against antigens expressed by murine FC, methods of generating the antibodies, and methods of using the same. MAb directed to markers that are expressed specifically or at higher levels by FC than by most other bone marrow cells have a wide range of applications, including but not limited to, rapid isolation of FC, identification of FC in a donor cell preparation, and molecular cloning of the genes encoding the corresponding target antigens.
    Type: Application
    Filed: October 8, 2002
    Publication date: March 20, 2003
    Applicant: University of Pittsburgh
    Inventors: Suzanne T. Ildstad, Christina Kaufman, Yolanda Colson
  • Publication number: 20020128449
    Abstract: The present invention relates to monoclonal antibodies (MAb) to hematopoietic facilitatory cells (FC). In particular, it relates to MAb against antigens expressed by murine FC, methods of generating the antibodies, and methods of using the same. MAb directed to markers that are expressed specifically or at higher levels by FC than by most other bone marrow cells have a wide range of applications, including but not limited to, rapid isolation of FC, identification of FC in a donor cell preparation, and molecular cloning of the genes encoding the corresponding target antigens.
    Type: Application
    Filed: January 30, 2002
    Publication date: September 12, 2002
    Applicant: University of Pittsburgh
    Inventors: Suzanne T. Ildstad, Christina Kaufman, Yolanda Colson
  • Publication number: 20010007021
    Abstract: The present invention relates to monoclonal antibodies (MAb) to hematopoietic facilitatory cells (FC). In particular, it relates to MAb against antigens expressed by murine FC, methods of generating the antibodies, and methods of using the same. MAb directed to markers that are expressed specifically or at higher levels by FC than by most other bone marrow cells have a wide range of applications, including but not limited to, rapid isolation of FC, identification of FC in a donor cell preparation, and molecular cloning of the genes encoding the corresponding target antigens.
    Type: Application
    Filed: August 2, 1999
    Publication date: July 5, 2001
    Inventors: SUZANNE T. ILDSTAD, CHRISTINA KAUFMAN, YOLANDA COLSON
  • Patent number: 6013519
    Abstract: The present invention relates to monoclonal antibodies (MAb) to hematopoietic facilitatory cells (FC). In particular, it relates to MAb against antigens expressed by murine FC, methods of generating the antibodies, and methods of using the same. MAb directed to markers that are expressed specifically or at higher levels by FC than by most other bone marrow cells have a wide range of applications, including but not limited to, rapid isolation of FC, identification of FC in a donor cell preparation, and molecular cloning of the genes encoding the corresponding target antigens.
    Type: Grant
    Filed: August 18, 1997
    Date of Patent: January 11, 2000
    Assignee: University of Pittsburgh
    Inventors: Suzanne T. Ildstad, Christina Kaufman, Yolanda Colson